Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.

Autor: Radin DP; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York., Shifman S; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York., Outhwaite IR; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York., Sharma A; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York., Bases R; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York., Seeliger MA; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York., Tsirka SE; Department of Pharmacological Sciences (D.P.R., S.S., I.R.O., A.S., M.A.S., S.E.T.) and Stony Brook Medical Scientist Training Program (D.P.R., S.S., I.R.O.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York Styliani-anna.Tsirka@stonybrook.edu.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Mar 15; Vol. 389 (1), pp. 51-60. Date of Electronic Publication: 2024 Mar 15.

Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation.

Autor: Yoon JY; Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Korea., Woo SM; Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Korea., Seo SU; Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Korea., Song SR; Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Korea., Lee SG; Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Korea., Kwon TK; Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Korea.; Center for Forensic Pharmaceutical Science, College of Pharmacy, Keimyung University, Daegu 42601, Korea.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 21; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 21.

Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation.

Autor: Yoon, Ji Yun¹ (AUTHOR) libra3009@naver.com, Woo, Seon Min¹ (AUTHOR) woosm724@gmail.com, Seo, Seung Un¹ (AUTHOR) sbr2010@hanmail.net, Song, So Rae¹ (AUTHOR) ssr02067@naver.com, Lee, Seul Gi¹ (AUTHOR) lsg100479@naver.com, Kwon, Taeg Kyu^1,2 (AUTHOR) kwontk@dsmc.or.kr

Publikováno v: International Journal of Molecular Sciences. Jan2022, Vol. 23 Issue 1, p17. 1p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme

Autor: Chowdhury, Sayan Mullick, Surhland, Cassandra, Sanchez, Zina, Chaudhary, Pankaj, Suresh Kumar, M.A., Lee, Stephen, Peña, Louis A., Waring, Michael, Sitharaman, Balaji, Naidu, Mamta

Publikováno v: In Nanomedicine: Nanotechnology, Biology, and Medicine January 2015 11(1):109-118